On this page
- The randomised evidence
- What the procedure actually is
- Where the stem cell label comes from
- Volume is not skin quality
- What else is sold under this heading
- Safety, which is not a formality here
- What is reasonable to expect
- What actually ages a face
- Questions worth asking
- Frequently asked questions
- Requesting a medical evaluation
Facial fat grafting is a genuine plastic surgery procedure with randomised trials behind it, performed by surgeons for decades. Stem cell facial rejuvenation is largely that procedure sold under a different name — and the difference between the operation and the label attached to it is worth a page of its own.
The randomised evidence
A randomised controlled trial examined fat grafting assisted by stromal vascular fraction for facial skin quality — Autologous fat graft assisted by stromal vascular fraction improves facial skin quality: A randomized controlled trial.
Plain fat transfer has been compared directly with cell-enriched grafting — Autologous fat transplantation versus adipose-derived stem cell-enriched lipografts: a study.
Fat has been compared against hyaluronic acid filler in a defined area — Comparative study of autologous fat vs hyaluronic acid in correction of the nasolabial folds.
A review covers current practice, including where it is contested — Autologous Fat Grafting in Facial Soft Tissue Defects: Application Status, Controversies and Future — and a systematic review covers adipose tissue in dermatology generally — Systematic review of the therapeutic roles of adipose tissue in dermatology.
What the procedure actually is
Fat is harvested by liposuction, usually from the abdomen or thighs, processed, and injected into the face to restore volume.
It works primarily by adding volume. A face loses fat, bone and skin elasticity with age, and putting fat back addresses the first of those directly and mechanically.
A proportion of the transferred fat does not survive, which is why results are unpredictable and why touch-up procedures are common. Survival depends on technique, handling and where the fat is placed.
That is a surgical procedure with surgical considerations, and it should be performed by a plastic surgeon.
Where the stem cell label comes from
Fat contains a mixed population of cells, including mesenchymal stromal cells, in what is called the stromal vascular fraction. Any fat graft therefore contains some.
Some techniques enrich the graft by adding cells separated from a second portion of fat, which is what the comparison trials examined.
That gives an accurate but misleading basis for the name. The patient hears regeneration; the procedure delivers volume.
Whether enrichment improves on plain grafting is precisely the question those trials asked, and it is not a settled matter.
Volume is not skin quality
Adding fat fills hollows. It does not change skin texture, pigmentation, fine wrinkling from sun damage, or laxity.
Those are separate problems with separate treatments: retinoids, sunscreen, chemical peels, laser resurfacing and energy devices, each with its own evidence.
The trial above measured facial skin quality specifically, which is why it is interesting — it tested a claim beyond the volume effect rather than assuming it.
A clinic promising volume, texture, tone and tightening from one procedure is promising across categories that respond to different treatments.
What else is sold under this heading
Exosome or conditioned medium products applied topically after microneedling or laser, marketed as regenerative. These are not cells and the evidence is thin — exosome therapy.
Platelet-rich plasma, the “vampire facial”, which has its own modest literature and is a different product — PRP therapy.
Intravenous infusions marketed for skin rejuvenation, for which there is no supporting trial evidence at all.
The word stem cell attaches to all of these commercially and describes only some of them accurately.
Safety, which is not a formality here
Fat injected into the face carries a rare but serious risk: material entering a blood vessel and blocking it, which can cause skin loss and, in the worst reported cases, blindness.
That risk applies to all facial injectables and is why anatomical knowledge and technique matter more than the product. It is a reason to choose the practitioner rather than the substance.
Liposuction at the donor site has its own risks, including contour irregularity and, rarely, more serious complications under general anaesthesia.
Infection, lumpiness, asymmetry and fat necrosis are the commoner problems. Documented adverse events covers harms across the field.
What is reasonable to expect
Restored facial volume with a proportion of the graft persisting long term, from a procedure with real randomised comparison against alternatives.
Possible improvement in skin quality where cell-enriched techniques are used, on early evidence.
Unpredictable graft survival, and the likely need for a second procedure.
No basis for claims about systemic rejuvenation, and none for an infusion doing anything to your face.
What actually ages a face
Volume loss is one of four processes and they progress at different rates. Bone resorbs, particularly around the eye socket and jaw, changing the underlying scaffold. Fat pads shrink and descend. Skin loses collagen and elastin. Repeated muscle movement etches lines.
Sun exposure drives much of the skin component, and the difference between sun-exposed and covered skin on the same person is the clearest demonstration of it available.
That matters for expectations: a treatment addressing one process cannot correct the others, and a face restored in volume alone can look full rather than younger.
It also means the cheapest intervention with the best long-term evidence is sunscreen, used consistently over decades rather than bought during a treatment trip.
Questions worth asking
- Is this fat grafting, cell-enriched grafting, a topical product, or an infusion?
- Is the person performing it a qualified plastic surgeon?
- What proportion of graft survival should I expect, and what happens if it is low?
- Is the claim about volume, skin quality, or both — and on what evidence?
- What is the plan if there is a vascular complication?
Hair thinning covers the adjacent aesthetic market, and the evidence levels explain the grading.
Frequently asked questions
Is this really stem cell therapy?
It is fat grafting. Fat contains stromal cells, so the label is accurate and misleading at once — the patient hears regeneration and the procedure delivers volume.
Does enriching the graft with cells help?
That is exactly what the comparison trials asked, and it is not settled. One randomised trial found improved facial skin quality with stromal enrichment.
Will it improve my skin texture?
Adding fat fills hollows. Texture, pigmentation and fine wrinkling respond to different treatments — retinoids, sunscreen, peels and resurfacing.
How long does it last?
A proportion of transferred fat does not survive and results are unpredictable. Touch-up procedures are common.
Is it safe?
The serious risk is material entering a blood vessel, which can cause skin loss and in rare reported cases blindness. That makes the practitioner’s anatomical knowledge the thing to assess.
What about an IV drip for skin?
There is no supporting trial evidence for intravenous infusions doing anything for facial appearance.
Requesting a medical evaluation
Nothing on this page establishes whether any treatment is appropriate for you. That needs your history, your imaging and your current medications read by a clinician. If you would like that review, send your records and we will tell you honestly whether there is anything worth discussing — including when the answer is no.
This page is general information, not medical advice, and does not create a doctor–patient relationship. Regenerative treatments discussed here are in most cases investigational. Discuss any treatment with a clinician who knows your history.